Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Response Modifiers
Neefe, John R.
Georgetown University, Washington, DC, United States
Search 6 grants from John Neefe
Search grants from Georgetown University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administrative and Statistical Core Resource
Effects of sex chromosome constitution on global gene expression
Methodology and Statistics Core
Evaluation of Inhibition of Shiv Replication by Sirna Vectors
Postdoctoral Training Program in Cancer Biology
Recently added grants:
Calcium: magnesium balance, microbiota, and necroptosis and inflammation
Deep learning to quantify glaucomatous damage on fundus photographs for teleophthalmology
Neural Mechanisms for memory-guided visual behavior in humans
Evolution of cis-regulatory sequences
Coupling promoter choice and alternative RNA splicing in the mammalian Protocadherin gene cluster
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007437-001010
Application #
3608506
Study Section
Project Start
1980-09-30
Project End
Budget Start
1985-12-31
Budget End
1986-04-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
NIH 1985
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
Publications
Neefe, J R; Phillips, E A; Treat, J
(1986)
Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferon.
Diagn Immunol 4:299-305
Comments
Be the first to comment on this grant